Cholesterol levels of Japanese dyslipidaemic patients with various comorbidities: BioBank Japan
H Yokomichi, H Noda, A Nagai, M Hirata… - Journal of …, 2017 - jstage.jst.go.jp
Background: Controlling serum cholesterol is critical to prevent cardiovascular disease in
patients with dyslipidaemia. Guidelines emphasise the need to select treatment for …
patients with dyslipidaemia. Guidelines emphasise the need to select treatment for …
[HTML][HTML] Cholesterol levels of Japanese dyslipidaemic patients with various comorbidities: BioBank Japan
H Yokomichi, H Noda, A Nagai, M Hirata… - Journal of …, 2017 - ncbi.nlm.nih.gov
Background Controlling serum cholesterol is critical to prevent cardiovascular disease in
patients with dyslipidaemia. Guidelines emphasise the need to select treatment for …
patients with dyslipidaemia. Guidelines emphasise the need to select treatment for …
[PDF][PDF] Cholesterol levels of Japanese dyslipidaemic patients with various comorbidities: BioBank Japan
H Yokomichi, H Noda, A Nagai, M Hirata… - Journal of …, 2017 - researchmap.jp
abstract Background: Controlling serum cholesterol is critical to prevent cardiovascular
disease in patients with dyslipidaemia. Guidelines emphasise the need to select treatment …
disease in patients with dyslipidaemia. Guidelines emphasise the need to select treatment …
[HTML][HTML] Cholesterol levels of Japanese dyslipidaemic patients with various comorbidities: BioBank Japan
H Yokomichi, H Noda, A Nagai, M Hirata… - Journal of …, 2017 - Elsevier
Background Controlling serum cholesterol is critical to prevent cardiovascular disease in
patients with dyslipidaemia. Guidelines emphasise the need to select treatment for …
patients with dyslipidaemia. Guidelines emphasise the need to select treatment for …
[PDF][PDF] Cholesterol levels of Japanese dyslipidaemic patients with various comorbidities: BioBank Japan
H Yokomichi, H Noda, A Nagai, M Hirata… - Journal of …, 2017 - cyberleninka.org
abstract Background: Controlling serum cholesterol is critical to prevent cardiovascular
disease in patients with dyslipidaemia. Guidelines emphasise the need to select treatment …
disease in patients with dyslipidaemia. Guidelines emphasise the need to select treatment …
Cholesterol levels of Japanese dyslipidaemic patients with various comorbidities: BioBank Japan
Y Hiroshi, N Hokuto, N Akiko, H Makoto, T Akiko… - Journal of …, 2017 - cir.nii.ac.jp
抄録< p> Background: Controlling serum cholesterol is critical to prevent cardiovascular
disease in patients with dyslipidaemia. Guidelines emphasise the need to select treatment …
disease in patients with dyslipidaemia. Guidelines emphasise the need to select treatment …
[PDF][PDF] Cholesterol levels of Japanese dyslipidaemic patients with various comorbidities: BioBank Japan
H Yokomichi, H Noda, A Nagai, M Hirata… - Journal of …, 2017 - researchgate.net
abstract Background: Controlling serum cholesterol is critical to prevent cardiovascular
disease in patients with dyslipidaemia. Guidelines emphasise the need to select treatment …
disease in patients with dyslipidaemia. Guidelines emphasise the need to select treatment …
Cholesterol levels of Japanese dyslipidaemic patients with various comorbidities: BioBank Japan
H Yokomichi, H Noda, A Nagai, M Hirata… - Journal of …, 2017 - search.proquest.com
Background: Controlling serum cholesterol is critical to prevent cardiovascular disease in
patients with dyslipidaemia. Guidelines emphasise the need to select treatment for …
patients with dyslipidaemia. Guidelines emphasise the need to select treatment for …
Cholesterol levels of Japanese dyslipidaemic patients with various comorbidities: BioBank Japan
Biobank Japan Cooperative … - Journal of …, 2017 - kyushu-u.elsevierpure.com
Background: Controlling serum cholesterol is critical to prevent cardiovascular disease in
patients with dyslipidaemia. Guidelines emphasise the need to select treatment for …
patients with dyslipidaemia. Guidelines emphasise the need to select treatment for …
Cholesterol levels of Japanese dyslipidaemic patients with various comorbidities: BioBank Japan.
H Yokomichi, H Noda, A Nagai, M Hirata, A Tamakoshi… - 2017 - cabidigitallibrary.org
Background: Controlling serum cholesterol is critical to prevent cardiovascular disease in
patients with dyslipidaemia. Guidelines emphasise the need to select treatment for …
patients with dyslipidaemia. Guidelines emphasise the need to select treatment for …